American Academy of Anti-Aging Medicine Peptide Therapy Certification – Module I 2026

A4M Peptide Therapy Certification Module I 2026 | Regenerative & Reparative Peptides, Metabolic Health, Immune Modulation, Tissue Repair, Longevity, Hormone Signaling & Clinical Peptide Science

The A4M Peptide Therapy Certification 2026 – Module I: Regenerative & Reparative Peptides is an advanced on-demand professional education program developed by the American Academy of Anti-Aging Medicine (A4M), focusing on peptide science, regenerative medicine, metabolic health, immune regulation, tissue repair, hormone signaling, cellular aging, and emerging therapeutic research.

As the foundational module of A4M’s two-part Peptide Therapy Certification program, Module I combines scientific principles with practical clinical considerations involving peptide-related interventions, pharmaceutical quality, regulatory status, individualized assessment, and patient safety.

Featuring physicians, pharmacists, researchers, and experienced clinicians, the curriculum explores the biological mechanisms and available evidence surrounding peptides involved in metabolic regulation, connective tissue biology, growth hormone signaling, immune pathways, gastrointestinal function, cellular communication, and neuroinflammation.

The A4M Peptide Therapy Certification Module I 2026 also provides extensive education on FDA regulatory considerations, state-level regulations, pharmaceutical manufacturing, sterile product quality control, clinical evidence assessment, and responsible integration of emerging therapies into professional medical practice.

Important peptide compounds and related therapeutic categories discussed include BPC-157, thymosin beta-4, KPV, RGN-259, VIP, Selank, CJC-1295, ipamorelin, sermorelin, tesamorelin, MOTS-c, thymosin alpha-1, GLP-1 receptor agonists, and other research compounds.

The course emphasizes that peptide-based medications differ significantly in clinical evidence, approval status, manufacturing quality, safety, and appropriate medical indications.

Through 18 scheduled educational sessions, the program introduces contemporary peptide medicine while addressing the scientific limitations and clinical responsibilities associated with this evolving field.

Course Details

• Course: American Academy of Anti-Aging Medicine Peptide Therapy Certification – Module I 2026
• Module Title: Regenerative & Reparative Peptides
• Provider: American Academy of Anti-Aging Medicine (A4M)
• Associated Organization: International Peptide Society
• Edition: 2026
• Module: I – Regenerative & Reparative Peptides
• Original Format: On-Demand Professional Education
• MedicalAmboss Package: Videos + Subtitles + PDFs
• Scheduled Educational Sessions: 18
• Published Instructional Schedule: Approximately 21.5 Hours, including a non-CME presentation
• Primary Specialty: Peptide Medicine / Regenerative Medicine
• Additional Focus: Internal Medicine, Endocrinology, Metabolic Health, Longevity, Clinical Pharmacology, Immunology and Tissue Repair
• Language: English
• Target Audience: Licensed Healthcare Practitioners
• Educational Methods: Expert Lectures, Regulatory Reviews, Scientific Presentations and Case-Based Discussions
• Official Certification Structure: Two Modules

The published instructional duration describes the original educational schedule and is not an independently verified runtime of the files delivered through MedicalAmboss.

Package Includes

• Module I Video Lectures
• Subtitle Files
• Course PDFs
• On-Demand Digital Educational Materials
• Downloadable Study Content
• Offline Study Access
• Digital Delivery

The package description is based on the supplied product information. Exact numbers of videos, subtitle files, and PDFs should be checked against the delivered files.

Target Audience

The program is intended for licensed healthcare practitioners interested in peptide science, regenerative medicine, metabolic regulation, longevity research, and responsible assessment of emerging therapies.

The target audience includes:

• Internal Medicine Physicians
• Family Medicine Physicians
• General Practitioners
• Endocrinologists
• Regenerative Medicine Physicians
• Preventive Medicine Physicians
• Functional Medicine Practitioners
• Integrative Medicine Physicians
• Sports Medicine Physicians
• Aesthetic Medicine Physicians
• Dermatologists
• Pharmacists
• Clinical Pharmacologists
• Osteopathic Physicians
• Physician Assistants
• Nurse Practitioners
• Registered Nurses
• Other Eligible Licensed Healthcare Professionals

The program is particularly relevant to clinicians seeking a structured understanding of peptide mechanisms, clinical evidence, regulatory requirements, product quality, and individualized patient assessment.

Program Overview

Peptides are amino acid-based molecules involved in diverse biological processes, including cell signaling, endocrine regulation, metabolic activity, immune function, and physiological homeostasis.

Certain peptide-based medications have established therapeutic applications supported by regulatory approval and clinical studies.

Other peptides discussed in regenerative, longevity, or performance medicine remain investigational, and their clinical effectiveness or long-term safety may not be established.

The A4M Peptide Therapy Certification Module I 2026 explores this expanding field through a curriculum that combines scientific, clinical, pharmaceutical, and regulatory perspectives.

The program covers:

• Peptide Medicine Fundamentals
• Regenerative and Reparative Peptides
• Metaflammation
• Metabolic Signaling
• Pharmaceutical Quality Assurance
• FDA Regulatory Considerations
• State-Level Regulations
• Sterile Manufacturing
• Compounding Considerations
• Personalized Clinical Assessment
• Nutrition and Lifestyle Integration
• Selective Androgen Receptor Modulators
• Body Composition
• Metabolic Health
• Glucose and Insulin Regulation
• Growth Hormone Signaling
• Immune Modulation
• Gut Biology
• Gastrointestinal Barrier Function
• Liposomal Oral Peptides
• Peptide Bioregulators
• Connective Tissue Repair
• Organ Repair Research
• Cellular Senescence
• DNA Damage
• Telomere Biology
• Hormone Receptor Modulation
• Neuroinflammation
• Autoimmune Mechanisms
• Patient Case Discussions

The program emphasizes evaluating potential clinical applications within the context of available scientific evidence and applicable regulations.

Learning Objectives

After completing the educational program, participants should be better able to:

1. Explain the fundamentals of peptide science and its relationship to metabolic signaling, immune regulation, endocrine function, and tissue biology.
2. Recognize the regulatory distinctions between FDA-approved peptide medications, investigational compounds, and compounded preparations.
3. Discuss pharmaceutical quality assurance, sterile manufacturing, product integrity, and related patient safety concerns.
4. Apply individualized clinical assessment principles when evaluating proposed peptide-related treatment approaches.
5. Review the role of nutrition, exercise, sleep, and lifestyle factors in metabolic and regenerative medicine.
6. Evaluate contemporary research involving body composition, insulin regulation, and peptide-related metabolic pathways.
7. Describe the relationship between gut barrier biology, inflammation, and immune modulation.
8. Critically assess scientific evidence involving regenerative and reparative peptides.
9. Review the physiological pathways associated with growth hormone signaling and related compounds.
10. Explain fundamental concepts involving cellular senescence, DNA damage, telomere biology, and aging research.
11. Review peptide-related research involving neuroinflammation, autoimmune mechanisms, and central nervous system signaling.
12. Integrate principles of evidence appraisal, clinical safety, regulatory compliance, and patient communication into professional decision-making.

Official Module I Curriculum

Session I – Peptide Science and Metabolic Signaling

1. Peptides Overview: Controlling Metaflammation, Metabolic Signaling & Clinical Value

Faculty: James LaValle, RPh, CCN, MT, DHM, DHPh

Duration: 1 Hour

This introductory presentation examines peptide-related biological signaling and its potential relevance to metabolic and inflammatory pathways.

Metaflammation refers to chronic, low-grade inflammatory processes associated with metabolic dysfunction.

Important topics include:

• Peptide Biology
• Metabolic Signaling
• Metaflammation
• Cellular Communication
• Inflammatory Pathways
• Energy Metabolism
• Clinical Research
• Strength of Evidence
• Translational Medicine
• Patient Assessment

The session establishes a scientific foundation for understanding subsequent discussions of peptide medicine.

Session II – FDA Regulations and Pharmaceutical Quality

2. FDA, Quality Assurance, and State-to-State Status: Where Are We Now and Where Is It Going?

Faculty: Tyler Chamberlain, PharmD, FAPC

Duration: 1.5 Hours

This presentation reviews the regulatory landscape affecting peptide products and related pharmaceutical preparations.

Important considerations include:

• FDA Regulatory Status
• Approved Prescription Medications
• Investigational Compounds
• Drug Compounding
• State-Level Regulations
• Quality Assurance
• Product Availability
• Clinical Documentation
• Professional Responsibilities
• Regulatory Changes

The session emphasizes the importance of understanding what is legally permitted and supported by evidence before considering a specific clinical intervention.

3. Manufacturing of Sterile Product Quality Control: Understanding the “For Human Use Difference”

Faculty: Anthony J. Campbell, PharmD, BCSCP

Duration: 1 Hour

This session examines pharmaceutical manufacturing and quality control principles relevant to sterile preparations intended for human use.

Important topics include:

• Sterile Product Manufacturing
• Pharmaceutical Quality
• Product Purity
• Sterility Assurance
• Contamination Prevention
• Manufacturing Standards
• Quality Testing
• Patient Safety
• Product Integrity
• Regulatory Compliance

4. Manufacturing of Sterile Product Quality Control – Continued

Faculty: Anthony J. Campbell, PharmD, BCSCP

Duration: 1 Hour

The second presentation expands upon sterile pharmaceutical manufacturing and associated quality considerations.

Important areas include:

• Sterile Compounding
• Quality Assurance
• Pharmaceutical Manufacturing Controls
• Product Handling
• Storage Considerations
• Potency and Purity
• Contamination Risks
• Documentation
• Quality Systems
• Patient Safety

These sessions highlight the importance of pharmaceutical quality when evaluating products intended for human administration.

Session III – Personalized Clinical Assessment

5. Personalized Peptide Protocols: Integrating Nutrition, Exercise & Lifestyle for Optimal Outcomes

Faculty: Stephanie Mazurek, PharmD

Duration: 30 Minutes

This session examines the relationship between proposed peptide-related interventions and broader patient management.

Important considerations include:

• Individualized Patient Assessment
• Nutrition
• Exercise
• Sleep
• Lifestyle
• Medical History
• Medication Review
• Metabolic Risk
• Treatment Goals
• Clinical Evidence
• Follow-Up Planning

The presentation emphasizes evaluating the full clinical context rather than focusing exclusively on individual compounds.

6. Integrating Peptides into Clinical Practice

Faculty: Erika Schwartz, MD

Duration: 1 Hour

This presentation reviews practical and professional considerations surrounding the discussion and evaluation of peptide-related therapies in clinical settings.

Relevant areas include:

• Clinical Assessment
• Professional Scope of Practice
• Treatment Eligibility
• Evidence Appraisal
• Safety Monitoring
• Regulatory Status
• Patient Counseling
• Documentation
• Clinical Workflow
• Individualized Decision-Making

7. Global Lifestyle Considerations in Peptide Medicine

Faculty: James LaValle, RPh, CCN, MT, DHM, DHPh

Duration: 1.5 Hours

This session reviews the broader physiological and lifestyle context relevant to metabolic health and regenerative medicine.

Important topics include:

• Nutritional Assessment
• Physical Activity
• Sleep
• Stress
• Metabolic Regulation
• Inflammation
• Body Composition
• Lifestyle Risk Factors
• Individual Patient Variability
• Long-Term Health

Session IV – Hormone Signaling and Body Composition

8. SARMs – What Are They? The Science and Controversy

Faculty: James LaValle, RPh, CCN, MT, DHM, DHPh

Duration: 1 Hour

This presentation reviews selective androgen receptor modulators and related scientific controversies.

Important considerations include:

• Selective Androgen Receptor Modulators
• Androgen Receptor Signaling
• Muscle Biology
• Body Composition
• Experimental Therapeutic Research
• Potential Adverse Effects
• Hormonal Disruption
• Regulatory Considerations
• Clinical Evidence Limitations

SARMs are not peptides, and their inclusion reflects their relationship to discussions of body composition and hormone signaling.

9. Body Composition and Metabolism

Faculty: Gordon Crozier, DO

Duration: 2.5 Hours

This presentation examines metabolic health and physiological factors relevant to body composition.

Important topics include:

• Body Composition Assessment
• Adipose Tissue
• Skeletal Muscle
• Metabolic Health
• Insulin Sensitivity
• Energy Balance
• Hormone Signaling
• Metabolic Biomarkers
• Lifestyle Considerations
• Individualized Clinical Assessment

The session provides context for understanding metabolic pathways and proposed peptide-related applications.

Session V – Immune Modulation and Gastrointestinal Health

10. All Roads of Health Lead to Immune Modulation and Gut Repair

Faculty: James LaValle, RPh, CCN, MT, DHM, DHPh

Duration: 1.5 Hours

This presentation examines the interactions between gastrointestinal biology, immune regulation, and inflammatory signaling.

Important topics include:

• Gut-Immune Interactions
• Gastrointestinal Barrier Function
• Immune Regulation
• Inflammatory Pathways
• Metabolic Signaling
• Gastrointestinal Physiology
• Gut Microbiome
• Clinical Research
• Peptide-Related Mechanisms
• Evidence Evaluation

11. Liposomal Oral Peptides: Precision Tools for Immune Regulation, Tissue Repair and Longevity Optimization

Faculty: Christopher Shade, PhD

Duration: 30 Minutes

Credit Status: Non-CME Presentation

This session explores liposomal delivery and related oral peptide formulation concepts.

Important considerations include:

• Liposomal Delivery Systems
• Oral Peptide Formulations
• Absorption
• Bioavailability
• Drug Delivery Research
• Formulation Quality
• Biological Stability
• Safety
• Clinical Evidence

This session is explicitly identified as non-CME in the original curriculum.

Session VI – Glucose Regulation and Peptide Bioregulators

12. The Role of Peptides in Glucose and Insulin Regulation – Balancing the Seesaw

Faculty: James LaValle, RPh, CCN, MT, DHM, DHPh

Duration: 1 Hour

This presentation reviews the relationship between peptide signaling, glucose homeostasis, and insulin-related metabolic pathways.

Important topics include:

• Glucose Regulation
• Insulin Signaling
• Metabolic Health
• Incretin Biology
• GLP-1 Receptor Agonists
• Energy Balance
• Metabolic Assessment
• Insulin Resistance
• Clinical Evidence
• Treatment Considerations

Some incretin-based medications have established clinical indications, whereas other peptide-related metabolic compounds remain investigational.

13. What’s New? Peptides and Bioregulators

Faculty: James LaValle, RPh, CCN, MT, DHM, DHPh

Duration: 1 Hour

This session examines developments in peptide bioregulator research and cellular signaling.

Important considerations include:

• Peptide Bioregulators
• Cellular Regulation
• Tissue Signaling
• Biological Mechanisms
• Regenerative Research
• Longevity Research
• Experimental Applications
• Scientific Evidence
• Safety
• Regulatory Status

The presentation emphasizes critical evaluation of evolving therapeutic claims.

Session VII – Tissue Repair and Regenerative Medicine

14. Optimize the Body to Heal from Injury: Connective Tissue Organ Repair

Faculty: Kathleen O’Neil-Smith, MD, FAARM

Duration: 1.5 Hours

This presentation reviews tissue repair biology and related regenerative medicine concepts.

Important topics include:

• Connective Tissue
• Tissue Recovery
• Wound Healing Biology
• Cellular Repair
• Inflammatory Signaling
• Regenerative Medicine
• BPC-157 Research
• Thymosin Beta-4
• Peptide-Related Mechanisms
• Clinical Evidence
• Safety Considerations

The session explores proposed biological approaches to tissue repair without establishing clinical effectiveness for investigational peptides.

Session VIII – Cellular Senescence and Longevity

15. Cellular Senescence: DNA Damage, Telomeres & Zombie Cells

Faculty: Kathleen O’Neil-Smith, MD, FAARM

Duration: 1 Hour

This presentation examines cellular aging and the biological characteristics of senescent cells.

Important topics include:

• Cellular Senescence
• DNA Damage
• Telomere Biology
• Cellular Stress
• Senescence-Associated Secretory Phenotype
• Chronic Inflammation
• Biological Aging
• Tissue Dysfunction
• Senolytic Research
• Longevity Science

The session provides an educational overview of emerging research rather than evidence that a particular peptide can reverse human aging.

Session IX – Hormonal Regulation and Receptor Signaling

16. Hormone Signaling and Hormone Receptor Modulation

Faculty: Marisol Duque, MD

Duration: 2 Hours

This presentation examines hormonal signaling pathways and their relationship to metabolic and neuroendocrine function.

Important considerations include:

• Hormone Signaling
• Hormone Receptors
• Endocrine Regulation
• Growth Hormone Axis
• GHRH
• Growth Hormone
• IGF-1
• Metabolic Regulation
• Receptor Modulation
• Peptide Signaling
• Clinical Evidence

The broader curriculum discusses compounds related to the growth hormone axis, including CJC-1295, ipamorelin, sermorelin, and tesamorelin.

Their approved indications, regulatory status, and safety profiles differ and must be evaluated individually.

Session X – Neuroinflammation and Autoimmunity

17. Intro to Brain Inflammation and Autoimmune

Faculty: Kathleen O’Neil-Smith, MD, FAARM

Duration: 1 Hour

This presentation introduces concepts involving inflammatory pathways, immune regulation, and nervous system biology.

Important topics include:

• Neuroinflammation
• Autoimmune Mechanisms
• Brain Health
• Immune Signaling
• Central Nervous System
• Neuroimmune Interactions
• Cellular Communication
• Peptide-Related Research
• Scientific Evidence
• Emerging Therapeutic Concepts

The session examines biological relationships that remain active areas of clinical and preclinical research.

Session XI – Clinical Cases

18. Patient Case Panel

Faculty: Led by James LaValle, RPh, CCN, MT, DHM, DHPh

Duration: 1 Hour

The concluding session integrates important themes from the Module I curriculum through patient-centered discussions.

Relevant areas include:

• Clinical History
• Laboratory Findings
• Metabolic Health
• Body Composition
• Lifestyle Factors
• Risk Assessment
• Evidence Evaluation
• Treatment Considerations
• Regulatory Status
• Clinical Monitoring
• Individualized Decision-Making

Major Peptide Categories Covered

Regenerative and Reparative Peptides

• BPC-157
• Thymosin Beta-4
• KPV
• RGN-259

These compounds are discussed in relation to tissue biology, inflammation, regeneration, and repair research.

Neurocognitive and CNS-Related Peptides

• VIP
• Selank
• PE-22-28
• PT-141

These compounds appear within the broader educational framework. Their proposed neurocognitive applications should not be interpreted as established clinical indications.

Growth Hormone Axis and Recovery

• CJC-1295
• Ipamorelin
• Sermorelin
• Tesamorelin

The curriculum explores pathways associated with growth hormone signaling, endocrine regulation, and related physiological processes.

Metabolic and Energy-Related Compounds

• MOTS-c
• Ghrelin-Related Compounds
• Macimorelin

These subjects are discussed in relation to metabolism and endocrine signaling.

Gut and Barrier Function

• Larazotide
• KPV

The educational focus includes gastrointestinal barrier biology and immune regulation.

Metabolic Regulation

• GLP-1 Receptor Agonists
• Tirzepatide and Related Incretin Therapies

The course distinguishes established medications from investigational compounds.

Immune Modulation

• Thymosin Alpha-1
• KPV
• VIP
• Related Adjunctive Compounds

Mitochondrial and Cellular Signaling

• Nicotinamide Riboside
• IRW
• LRP / LQP
• TUDCA

Some of these compounds are not peptides and are included as related research subjects.

Major Topics Covered

• A4M Peptide Therapy Certification 2026
• Module I Regenerative and Reparative Peptides
• Peptide Medicine
• Regenerative Medicine
• Anti-Aging Medicine
• Longevity Medicine
• Metabolic Health
• Metaflammation
• Cellular Signaling
• FDA Peptide Regulations
• Pharmaceutical Quality Assurance
• Sterile Manufacturing
• Compounding Standards
• Personalized Clinical Assessment
• Nutrition and Lifestyle
• Body Composition
• SARMs
• Glucose Regulation
• Insulin Signaling
• GLP-1 Therapies
• Immune Modulation
• Gut Barrier Function
• Tissue Repair
• Connective Tissue Recovery
• Peptide Bioregulators
• Cellular Senescence
• DNA Damage
• Telomere Biology
• Hormone Receptor Modulation
• Growth Hormone Axis
• Neuroinflammation
• Autoimmune Mechanisms
• BPC-157
• Thymosin Beta-4
• KPV
• VIP
• Selank
• CJC-1295
• Ipamorelin
• Sermorelin
• Tesamorelin
• MOTS-c
• Thymosin Alpha-1
• Clinical Peptide Safety
• Evidence-Based Medicine

Regenerative and Reparative Peptide Research

Regenerative medicine explores biological mechanisms involved in tissue maintenance, cellular signaling, and recovery.

The Module I curriculum reviews peptide-related research concerning connective tissue biology, inflammation, and physiological repair mechanisms.

Compounds such as BPC-157, thymosin beta-4, and KPV are discussed within this broader scientific context.

However, preclinical findings do not automatically establish clinical effectiveness, and the regulatory status of individual compounds must be considered separately.

Metabolic Health and Body Composition

Metabolic regulation is a central topic of the A4M Module I program.

The curriculum examines:

• Metabolic Signaling
• Glucose Regulation
• Insulin-Related Pathways
• Body Composition
• Adipose Tissue
• Skeletal Muscle
• Inflammation
• Hormonal Regulation
• Lifestyle Factors

These subjects support a broader understanding of the relationship between metabolism, endocrine function, and clinical assessment.

Immune Modulation and Gut Biology

The gastrointestinal and immune systems interact through numerous biological processes.

The program explores immune signaling, gastrointestinal barrier function, inflammation, and related peptide research.

Important considerations include gut-immune interactions, clinical evidence, and the limitations of proposed treatment approaches.

Cellular Senescence and Longevity

Research into biological aging examines the relationship between cellular stress, senescence, DNA damage, telomeres, and age-associated disease.

The course introduces these concepts and considers their relevance to emerging longevity research.

These topics should be interpreted as educational and investigational unless supported by established clinical evidence for a specific intervention.

Hormone Signaling and Endocrine Regulation

Peptide-related pathways contribute to the regulation of several endocrine processes.

The curriculum includes discussions involving:

• Growth Hormone Signaling
• GHRH
• IGF-1
• Hormonal Receptors
• Metabolic Regulation
• Neuroendocrine Function
• Related Peptide Compounds

The educational focus is on understanding biological mechanisms and evaluating the safety and evidence associated with proposed interventions.

Pharmaceutical Quality and Regulatory Compliance

A distinguishing feature of the Module I curriculum is its emphasis on quality assurance and regulatory considerations.

The course examines:

• FDA Status
• State Regulations
• Compounding
• Sterile Manufacturing
• Product Purity
• Product Quality
• Patient Safety
• Legal Availability
• Clinical Evidence

Healthcare professionals must evaluate each compound individually rather than assuming that inclusion in a peptide medicine program establishes its safety or approval.

Official Faculty

The published 2026 Module I faculty includes:

• Anthony J. Campbell, PharmD, BCSCP
• Tyler Chamberlain, PharmD, FAPC
• Gordon Crozier, DO
• Marisol Duque, MD
• James LaValle, RPh, CCN, MT, DHM, DHPh
• Stephanie Mazurek, PharmD
• Kathleen O’Neil-Smith, MD, FAARM
• Erika Schwartz, MD
• Christopher Shade, PhD

The faculty include physicians, pharmacists, and researchers involved in peptide medicine, pharmaceutical quality, regenerative medicine, metabolism, and clinical education.

Certification Requirements

The official A4M Peptide Therapy Certification consists of two modules.

To complete the provider’s certification pathway, participants must satisfy:

• Completion of Module I
• Completion of Module II
• Active A4M or International Peptide Society Membership
• Applicable Provider Eligibility and Assessment Requirements

Module I alone does not constitute the complete A4M Peptide Therapy Certification.

Continuing Medical Education

The original A4M program includes professional education opportunities under the provider’s accredited activities.

The published Module I on-demand schedule contains approximately 21.5 hours of instruction, including a designated non-CME presentation.

The instructional duration should not be treated automatically as the number of accredited CME credits available for a particular purchase.

Important CME and Certification Notice

Purchasing separately distributed educational files through MedicalAmboss does not itself provide:

• Official A4M Certification
• Official CME Credits
• A4M Course Registration
• Completion Certificates
• International Peptide Society Membership
• Official Examinations
• A4M Learning Platform Access
• Publisher-Hosted Educational Benefits

Why This Course Is Relevant

The A4M Peptide Therapy Certification 2026 – Module I: Regenerative & Reparative Peptides provides a structured introduction to contemporary peptide medicine and related scientific research.

The program combines peptide biology, metabolic health, tissue repair, immunology, endocrine signaling, pharmaceutical quality, regulatory compliance, and clinical evidence evaluation.

Unlike courses focusing exclusively on individual peptide compounds, Module I also explores the pharmaceutical, clinical, and legal considerations necessary for responsible assessment of emerging therapies.

Its multidisciplinary structure is relevant to physicians, pharmacists, and other licensed healthcare professionals seeking an organized educational foundation in peptide science and related research.

Official Program Reference and MedicalAmboss Purchase Scope

Official A4M 2026 Program:

https://www.a4m.com/peptide-therapy-certification-on-demand-2026.html

Official Certification Information:

https://learn.a4m.com/pages/peptide-therapy-certification

MedicalAmboss Product:

https://medicalamboss.com/product/american-academy-of-anti-aging-medicine-peptide-therapy-certification-module-i-2026/

These references describe the original educational curriculum, faculty, and certification pathway.

They do not independently establish the exact inventory of digital files included in the MedicalAmboss listing.

MedicalAmboss File Scope: This listing describes the educational subject matter for reference. Provider registration, live attendance, streaming-platform access, CME or other credit, certificates, memberships, apps, accounts, and publisher-hosted extras are not included unless explicitly listed as store files.

Short Description

A4M Peptide Therapy Certification 2026 – Module I: Regenerative & Reparative Peptides provides advanced educational training in peptide science, regenerative medicine, metabolic health, tissue repair, immune modulation, hormone signaling, and longevity research.

The program includes 18 scheduled sessions covering peptide mechanisms, FDA regulations, pharmaceutical quality assurance, sterile manufacturing, individualized clinical assessment, body composition, glucose and insulin regulation, gut biology, connective tissue recovery, cellular senescence, hormone receptors, and neuroinflammation.

Module I Course Content

Lecture	Duration
Peptides Overview: Controlling Metaflammation, Metabolic Signaling & Clinical Value	1 hr
FDA, Quality Assurance & State-to-State Status	1.5 hr
Manufacturing of Sterile Product Quality Control — Parts I & II	2 hrs
Personalized Peptide Protocols	0.5 hr
Integrating Peptides into Clinical Practice	1 hr
Global Lifestyle Considerations in Peptide Medicine	1.5 hr
SARMs: Science & Controversy	1 hr
Body Composition & Metabolism	2.5 hrs
Immune Modulation & Gut Repair	1.5 hr
Liposomal Oral Peptides	0.5 hr
Peptides in Glucose & Insulin Regulation	1 hr
Peptides & Bioregulators	1 hr
Connective Tissue & Organ Repair	1.5 hr
Cellular Senescence, DNA Damage & Telomeres	1 hr
Hormone Signaling & Receptor Modulation	2 hrs
Brain Inflammation & Autoimmune	1 hr
Patient Case Panel	1 hr

Who Is This Course For?

Designed for licensed healthcare practitioners interested in peptide medicine, anti-aging and longevity medicine, regenerative medicine, functional medicine, metabolic health, hormone optimization, and advanced clinical therapeutics.